With your support, Children with Cancer UK is able to invest in specialist brain tumour research which would otherwise go unfunded,
keeping more families together.
Each year, we actively support Brain Tumour Awareness Month to highlight the importance of increasing funding for childhood brain tumour research. On this website and in our social media, you can find information about the difference our research is making and why it’s so important to fund more research into childhood brain tumours.The importance of research into brain tumours
Blake’s Train & Tube appeal
You may see copies of Blake’s appeal on trains and the London Underground over the coming weeks.
Brain tumours like Blake’s cause more deaths than any other childhood cancer.
We’re asking for help to find safer and kinder treatments that will save more children’s lives.See Blake's appeal
Some brain tumours are curable, using aggressive treatments including surgery, chemotherapy and/or radiotherapy. Other brain tumours, however, remain incurable, with no effective treatment. Some children may survive only a few months from diagnosis.
For those who survive long-term, survival may come at high cost. The aggressive treatments can harm developing brains, causing physical and mental disabilities and a range of health problems.
We urgently need to fund more research to improve our understanding of childhood brain tumours, find more effective, less damaging treatments and save more young lives.
Dylan was diagnosed with brain and spinal tumours when he was two years old. His mum, Jessica, tells us her story in the six short podcasts.Listen to mum Jessica tell Dylan's story
During Brain Tumour Awareness Month you showed your support and spread awareness by using one of our custom made social media profile frames.
Research into brain tumours, in general, and childhood brain tumours, in particular, has not been well-funded in the past despite the very high burden imposed by these tumours.
To address this, in 2014 we launched a new initiative to drive progress in childhood brain tumour research, committing funds of at least £3 million over three years for new brain tumour research.
Our researchers work together to share samples, data and expertise, both nationally and internationally.
The first tranche of funding was awarded in March 2015 for four exciting new project grants worth £1.8 million in total.
With this funding, four groups of researchers are taking forward vital research into four different types of childhood brain tumour: ependymoma, medulloblastoma, craniopharyngioma and high grade glioma.
An important feature of the four new projects is that they are all strongly collaborative, with researchers working together to share samples, data and expertise, both nationally and internationally.
In 2016, we focused on the very specific issue of drug delivery in childhood brain tumours. One of the major challenges in treating brain tumours is getting drugs through the ‘blood-brain barrier’ to reach the tumour. We hosted a highly successful workshop on this topic in February 2016, bringing together scientists and clinicians from around the world to share experiences and forge new research collaborations.
In December 2016 the second phase of funding was agreed and an additional four projects were awarded at a total cost of £1.24 million. We invited research applications which sought to enhance the effectiveness of therapy through improved drug delivery systems or the use of novel technologies. The four projects use distinctly different approaches to deliver treatments of brain tumour patients.
This has brought our total expenditure of the Brain Tumour Initiative to over £3 million as planned in 2014.
Diffuse intrinsic pontine glioma (DIPG) is a childhood brain tumour that currently kills over 90% of children diagnosed ...Read more
In 2014, in response to the apparent dearth of funding going into paediatric brain tumour research, we ring-fenced ...Read more